Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study

被引:21
作者
Elia, Evelin M. [1 ]
Quintana, Ramiro [2 ]
Carrere, Carlos [2 ]
Bazzano, Maria V. [3 ]
Rey-Valzacchi, Gaston [2 ]
Paz, Dante A. [1 ,3 ]
Pustovrh, Maria C. [1 ,4 ]
机构
[1] IFIBYNE CONICET UBA, Inst Fisiol Biol Mol & Neurociencias, Fac Ciencias Exactas & Nat, Lab Biol Desarrollo, Buenos Aires, DF, Argentina
[2] Procrearte Med Reprod & Mol, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Det Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina
[4] Univ Valle, Fac Salud, Escuela Ciencias Basicas, Dept Morfol, Cali, Colombia
关键词
ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; IN-VITRO FERTILIZATION; VASCULAR-PERMEABILITY; DOUBLE-BLIND; CYCLOOXYGENASE-2; COX-2; FOLLICULAR-FLUID; GNRH ANTAGONIST; NITRIC-OXIDE; WOMEN;
D O I
10.1186/1757-2215-6-62
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian hyperstimulation syndrome (OHSS). Metformin reduces the risk of OHSS but little is known about the possible effects and mechanisms of action involved. Objective: To evaluate whether metformin attenuates some of the ovarian adverse effects caused by OHSS and to study the mechanisms involved. Material and methods: A rat OHSS model was used to investigate the effects of metformin administration. Ovarian histology and follicle counting were performed in ovarian sections stained with Masson trichrome. Vascular permeability was measured by the release of intravenously injected Evans Blue dye (EB). VEGF levels were measured by commercially immunosorbent assay kit. COX-2 protein expression was evaluated by western blot and NOS levels were analyses by immunohistochemistry. Results: Animals of the OHSS group showed similar physiopathology characteristics to the human syndrome: increased body weight, elevated progesterone and estradiol levels (P<0.001), increased number of corpora lutea (P<0.001), higher ovarian VEGF levels and vascular permeability (P<0.001 and P<0.01); and treatment with metformin prevented this effect (OHSS+M group; P<0.05). The vasoactive factors: COX-2 and NOS were increased in the ovaries of the OHSS group (P<0.05 and P<0.01) and metformin normalized their expression (P<0.05); suggesting that metformin has a role preventing the increased in vascular permeability caused by the syndrome. Conclusion: Metformin has a beneficial effect preventing OHSS by reducing the increase in: body weight, circulating progesterone and estradiol and vascular permeability. These effects of metformin are mediated by inhibiting the increased of the vasoactive molecules: VEGF, COX-2 and partially NOS. Molecules that are increased in OHSS and are responsible for a variety of the symptoms related to OHSS.
引用
收藏
页数:9
相关论文
共 54 条
[1]   The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome [J].
Albert, C ;
Garrido, N ;
Mercader, A ;
Rao, CV ;
Remohí, J ;
Simón, C ;
Pellicer, A .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (05) :409-418
[2]   The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial† [J].
Busso, Cristiano ;
Fernandez-Sanchez, Manuel ;
Antonio Garcia-Velasco, Juan ;
Landeras, Jose ;
Ballesteros, Augustin ;
Munoz, Elkin ;
Gonzalez, Sandra ;
Simon, Carlos ;
Arce, Joan-Carles ;
Pellicer, Antonio .
HUMAN REPRODUCTION, 2010, 25 (04) :995-1004
[3]   A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary [J].
Cheng, GJ ;
Zhang, WH ;
Mäkinen, S ;
Saji, S ;
Warner, M ;
Gustafsson, JÅ ;
Hovatta, O .
BIOLOGY OF REPRODUCTION, 2002, 66 (01) :77-84
[4]   Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer [J].
Cianchi, F ;
Cortesini, C ;
Fantappiè, O ;
Messerini, L ;
Sardi, I ;
Lasagna, N ;
Perna, F ;
Fabbroni, V ;
Di Felice, A ;
Perigli, G ;
Mazzanti, R ;
Masini, E .
CLINICAL CANCER RESEARCH, 2004, 10 (08) :2694-2704
[5]  
DAngelo A., 2007, COCHRANE DB SYST REV, V3
[6]   Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome [J].
De Leo, V ;
la Marca, A ;
Ditto, A ;
Morgante, G ;
Cianci, A .
FERTILITY AND STERILITY, 1999, 72 (02) :282-285
[7]   The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice [J].
Elia, E. ;
Sander, V. ;
Luchetti, C. G. ;
Solano, M. E. ;
Di Girolamo, G. ;
Gonzalez, C. ;
Motta, A. B. .
MOLECULAR HUMAN REPRODUCTION, 2006, 12 (08) :475-481
[8]   Link between metformin and the peroxisome proliferator-activated receptor γ pathway in the uterine tissue of hyperandrogenized prepubertal mice [J].
Elia, Evelin M. ;
Pustovrh, Carolina ;
Amalfi, Sabrina ;
Devoto, Luigi ;
Beatriz Motta, Alicia .
FERTILITY AND STERILITY, 2011, 95 (08) :2534-U556
[9]   The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].
Engmann, Lawrence ;
DiLuigi, Andrea ;
Schmidt, David ;
Nulsen, John ;
Maier, Donald ;
Benadiva, Claudio .
FERTILITY AND STERILITY, 2008, 89 (01) :84-91
[10]   The effect of metformin treatment on VEGF and PAI-1 Levels in obese type 2 diabetic patients [J].
Ersoy, Canan ;
Kiyici, Sinem ;
Budak, Ferah ;
Oral, Barbaros ;
Guclu, Metin ;
Duran, Cevdet ;
Selimoglu, Hadi ;
Erturk, Erdinc ;
Tuncel, Ercan ;
Imamoglu, Sazi .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (01) :56-60